Literature DB >> 19152510

Population reference intervals for minimal erythemal doses in monochromator phototesting.

Harry Moseley1, Hannah Naasan, Robert S Dawe, Julie Woods, James Ferguson.   

Abstract

BACKGROUND/
PURPOSE: Monochromator phototesting, to measure the minimal erythemal dose (MED), is useful in investigating patients with abnormal photosensitivity at different wavelengths. It relies on access to reliable, up-to-date data on the MED in normal individuals. The purpose of this study was to determine MED in normal subjects at different wavebands and compare these with historical controls.
METHODS: The study group consisted of 415 normal individuals (349 males) of skin types I-III living in Scotland. Age range was 18-83 years (median 31 years). Phototesting was performed using a monochromator at prescribed wavelengths from 295 to 430 nm. All calibrations were traceable to the National Physical Laboratory. Quality systems were maintained to ISO 9001 and ISO 17025 international standards and ultraviolet (UV) measurements accredited by the United Kingdom Accreditation Service (UKAS).
RESULTS: The 95% reference interval (99% confidence interval for this) ranged from 6.8 to 27 mJ/cm(2) at 295 nm to >82,000 mJ/cm(2) at 430 nm.
CONCLUSIONS: Results of the current investigation are broadly in agreement with values published 25 years ago by this centre. This validates the phototesting process based on the use of monochromators with attention to careful control of conditions during UV exposure and MED reading, supported by dosimetric calibration.

Entities:  

Mesh:

Year:  2009        PMID: 19152510     DOI: 10.1111/j.1600-0781.2009.00391.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  1 in total

1.  Filaggrin genotype does not determine the skin's threshold to UV-induced erythema.

Authors:  Deborah Forbes; Leona Johnston; June Gardner; Stephanie F MacCallum; Linda E Campbell; Albena T Dinkova-Kostova; W H Irwin McLean; Sally H Ibbotson; Robert S Dawe; Sara J Brown
Journal:  J Allergy Clin Immunol       Date:  2016-01-29       Impact factor: 10.793

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.